Last updated on January 2020

Study of Tumour Focused Radiotherapy for Bladder Cancer


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: bladder cancer | Urothelial Cancer | Bladder Carcinoma
  • Age: Between 16 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Written informed consent
  • Age 16 years
  • Histologically or cytologically confirmed transitional cell carcinoma (TCC) of the bladder
  • Unifocal bladder TCC staged T2-T4a N0 M0
  • Fit to receive a radical course of radiotherapy
  • WHO performance status 0-2
  • Willing and able to comply with study procedures and follow up schedule

Exclusion Criteria:

  • Nodal or metastatic disease
  • Widespread carcinoma in situ (CIS) or CIS remote from muscle invasive tumour or multifocal invasive disease
  • Simultaneous TCC in upper tract or urethra
  • Pregnancy
  • Active malignancy within 2 years of randomisation (not including non melanomatous skin carcinoma, previous non muscle invasive bladder tumours, NCCN low risk prostate cancer (T1/T2a, Gleason 6 PSA <10), in situ carcinoma of any site)
  • Any other conditions that in the Principal Investigator's opinion would be a contra-indication to radiotherapy (e.g. previous pelvic radiotherapy / inflammatory bowel disease)

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.